The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses

Hill, M. N., Haney, M., Hillard, C. J., Karhson, D. S., & Vecchiarelli, H. A. (2023). The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses. Psychological Medicine, 53(15), 7006–7024. https://doi.org/10.1017/s0033291723002465
Authors:
Matthew N Hill
Margaret Haney
Cecilia J Hillard
Debra S Karhson
Haley A Vecchiarelli
Affiliated Authors:
Margaret Haney
Columbia Affiliation:
Subjects:
Mental Disorders (MeSH)
Cannabis (MeSH)
Hallucinogens (MeSH)
Author Keywords:
anxiety
cb1
faah
magl
ptsd
autism
cannabis
endocannabinoid
psychiatric illness
substance use disorder
elink
Publication Type:
Article
Unique ID:
10.1017/s0033291723002465
PMID:
37671673
DOI:
10.1017/s0033291723002465
Journal:
Psychological Medicine
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: